Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03685799
Other study ID # PatheBarett-IPC 2016-005
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2016
Est. completion date June 2016

Study information

Verified date September 2018
Source Institut Paoli-Calmettes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Influence of histological concordance on the risk of recurrence:

the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate.


Description:

Influence of histological concordance on the risk of recurrence:

the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients with DHG on Barrett's esophagus on endoscopic biopsies followed by endoscopic resection.

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Pathological revision
Pathological revision

Locations

Country Name City State
France Institut Paoli-Calmettes Marseille Bouches-du Rhône

Sponsors (1)

Lead Sponsor Collaborator
Institut Paoli-Calmettes

Country where clinical trial is conducted

France, 

References & Publications (1)

Godat S, Caillol F, Autret A, Bories E, Pesenti C, Ratone JP, De Cassan C, Poizat F, Giovannini M. Endotherapy in case of relapse of neoplastic Barrett's esophagus after successful initial endoscopic resection. Surg Endosc. 2017 Sep;31(9):3703-3710. doi: — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Influence of histological concordance on the risk of recurrence the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate. 1 day
Secondary Identification of histological factors of recurrence. Identification of histological factors of recurrence. 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT05530343 - Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance N/A
Recruiting NCT06071845 - Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples N/A
Recruiting NCT04001478 - Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
Recruiting NCT04295811 - Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC N/A
Not yet recruiting NCT04843397 - Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study
Completed NCT03120195 - EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study N/A
Recruiting NCT05753748 - Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia N/A
Enrolling by invitation NCT04561791 - Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting N/A
Completed NCT04293458 - Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE N/A
Recruiting NCT06030180 - CLUE: CLinical Utility Study of EsoGuard N/A
Active, not recruiting NCT02994693 - Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
Not yet recruiting NCT05276791 - EMR Versus ESD for Barrett's Neoplasia N/A
Completed NCT03193216 - The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus Phase 2
Recruiting NCT05983419 - Complete Resection of Barrett's Esophagus Harboring Neoplasia With Endoscopic Submucosal Dissection. N/A
Completed NCT06381583 - A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
Recruiting NCT05965999 - Lucid Registry Study
Completed NCT04316975 - Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus N/A